Presentation is loading. Please wait.

Presentation is loading. Please wait.

Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis  E. Michael Lewiecki, John P. Bilezikian,

Published byAlexandrina Gardner Modified over 6 years ago

Similar presentations

Presentation on theme: "Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis  E. Michael Lewiecki, John P. Bilezikian,"— Presentation transcript:

1 Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis  E. Michael Lewiecki, John P. Bilezikian, John J. Carey, Richard M. Dell, Catherine M. Gordon, Steven T. Harris, Michael R. McClung, Paul D. Miller, Michael Rosenblatt  Journal of Clinical Densitometry  Volume 21, Issue 1, Pages 3-21 (January 2018) DOI: /j.jocd Copyright © 2017 The International Society for Clinical Densitometry Terms and Conditions

2 Fig. 1 Algorithm for long-term management of osteoporosis.
Journal of Clinical Densitometry  , 3-21DOI: ( /j.jocd ) Copyright © 2017 The International Society for Clinical Densitometry Terms and Conditions

3 Fig. 2 Decision points for patients on an antiresorptive medication. This figure represents the decision points for patients on an antiresorptive medication such as a bisphosphonate. Patients at high risk of AFF should be evaluated after 3 years on treatment with a DXA scan and metabolic bone workup to see if further treatment is justified. Currently, no AFF risk calculator has been published but groups at high risk of AFF have been identified such as younger Asian women. Regardless of duration of treatment, patients with thigh or hip pain on antiresorptive medication should be considered as possibly having a stress reaction or incomplete AFF and an appropriate workup should be considered. The considerations for a drug holiday and when to restart antiresorptive medication are also outlined and discussed in the paper. AFF, atypical femur fracture; DXA, dual-energy X-ray absorptiometry; MRI, magnetic resonance imaging; Rx, treatment. Journal of Clinical Densitometry  , 3-21DOI: ( /j.jocd ) Copyright © 2017 The International Society for Clinical Densitometry Terms and Conditions

4 Fig. 3 Proposed guidelines for management of patients on with an atypical femoral fracture, adapted from multiple sources. AFF, atypical femur fracture; BP, bisphosphonate. Journal of Clinical Densitometry  , 3-21DOI: ( /j.jocd ) Copyright © 2017 The International Society for Clinical Densitometry Terms and Conditions

5 Fig. 4 (A) Osteonecrosis of the jaw in a patient with high bisphosphonate therapy for metastatic cancer. (B) Healing after 6 months of treatment with teriparatide. Journal of Clinical Densitometry  , 3-21DOI: ( /j.jocd ) Copyright © 2017 The International Society for Clinical Densitometry Terms and Conditions

Download ppt "Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis  E. Michael Lewiecki, John P. Bilezikian,"

Similar presentations

Atypical Fractures of the Femur: Evaluation and Treatment by Travis Blood, R.J. Feller, Eric Cohen, Christopher T. Born, and Roman Hayda JBJS Reviews Volume.

Atypical Fractures of the Femur: Evaluation and Treatment by Travis Blood, R.J. Feller, Eric Cohen, Christopher T. Born, and Roman Hayda JBJS Reviews Volume.
Bone Turnover Suppression Based on an ASBMR/ECTS Clincal Debate “Too Much Suppression of Turnover Is Bad for Bone” Co-Chairs: Socrates Papapoulos, Douglas.

Bone Turnover Suppression Based on an ASBMR/ECTS Clincal Debate “Too Much Suppression of Turnover Is Bad for Bone” Co-Chairs: Socrates Papapoulos, Douglas.
Atypical Femoral Fractures: What Do We Know About Them?

Atypical Femoral Fractures: What Do We Know About Them?
Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know by Richard M. Dell, Denise Greene, David Anderson, and Kathy Williams J Bone.

Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know by Richard M. Dell, Denise Greene, David Anderson, and Kathy Williams J Bone.
Jacobi Ambulatory Care Service The next steps…. Jacobi Ambulatory Care Service Doing More by doing less Tips.

Jacobi Ambulatory Care Service The next steps…. Jacobi Ambulatory Care Service Doing More by doing less Tips.
Osteoporosis Disease Management: The Role of the Orthopaedic Surgeon by Richard Dell, Denise Greene, Steven R. Schelkun, and Kathy Williams J Bone Joint.

Osteoporosis Disease Management: The Role of the Orthopaedic Surgeon by Richard Dell, Denise Greene, Steven R. Schelkun, and Kathy Williams J Bone Joint.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages 179-202 (January 2016) DOI: 10.1016/j.jhep.2015.07.040.

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages 67-76 (January 2012) DOI:

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Ola Wallengren, Ingvar Bosaeus, Kent Lundholm  Clinical Nutrition 

Ola Wallengren, Ingvar Bosaeus, Kent Lundholm  Clinical Nutrition 
Volume 63, Issue 1, Pages (July 2015)

Volume 63, Issue 1, Pages (July 2015)
Pelvic Periprosthetic Bone Mineral Density Measurement Around Cemented vs Cementless Acetabular Prostheses  Raveen L. Jayasuriya, J. Mark Wilkinson  Journal.

Pelvic Periprosthetic Bone Mineral Density Measurement Around Cemented vs Cementless Acetabular Prostheses  Raveen L. Jayasuriya, J. Mark Wilkinson  Journal.
Managing Cancer Pain: Basic Principles and Invasive Treatments

Managing Cancer Pain: Basic Principles and Invasive Treatments
Managing Metastatic Bone Pain: The Role of Bisphosphonates

Managing Metastatic Bone Pain: The Role of Bisphosphonates
Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial  Karen A. Beattie,

Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial  Karen A. Beattie,
Effects of the Assessment of 4 Determinants of Structural Geometry on QCT- and DXA- Derived Hip Structural Analysis Measurements in Elderly Women  Benjamin.

Effects of the Assessment of 4 Determinants of Structural Geometry on QCT- and DXA- Derived Hip Structural Analysis Measurements in Elderly Women  Benjamin.
Effects of Exemestane and Tamoxifen Treatment on Bone Texture Analysis Assessed by TBS in Comparison With Bone Mineral Density Assessed by DXA in Women.

Effects of Exemestane and Tamoxifen Treatment on Bone Texture Analysis Assessed by TBS in Comparison With Bone Mineral Density Assessed by DXA in Women.
Sharon H. Chou, Jessica Hwang, Siu-Ling Ma, Tamara Vokes 

Sharon H. Chou, Jessica Hwang, Siu-Ling Ma, Tamara Vokes 
Cidofovir Treatment of Progressive Multifocal Leukoencephalopathy in a Patient Receiving Highly Active Antiretroviral Therapy  Raymund R. Razonable, MD,

Cidofovir Treatment of Progressive Multifocal Leukoencephalopathy in a Patient Receiving Highly Active Antiretroviral Therapy  Raymund R. Razonable, MD,
Ronald D. Emkey, MD, Mark Ettinger, MD 

Ronald D. Emkey, MD, Mark Ettinger, MD 
Managing Metastatic Bone Pain: The Role of Bisphosphonates

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Similar presentations

Ads by Google